News

A study has developed a scoring system to predict the risk of disease recurrence after stem cell transplantation in leukaemia patients

In 2023, semaglutide emerged as the top-selling drug in the USA, generating $13.8 billion in sales.

This variant results in reduced STAT6 protein levels, dampened IL-4 responses, and lower IgE and eosinophil counts in the blood.

Neoantigen DNA vaccines show safety and efficacy in reducing breast cancer recurrence, promising a personalised approach to immunotherapy in high-risk patients.

Kidney function decline in ATTR-CM predicts worse outcomes. Monitoring eGFR changes can guide interventions, improving clinical care for this progressive disease.

Upper extremity disability in rheumatoid arthritis fluctuates over time, with pain and hand function playing a critical role, study finds.

This new research sheds light on shared and subtype-specific genetic variations and points to potential targets

Restaging MRI is a powerful tool for predicting survival and organ preservation in rectal cancer patients after total neoadjuvant therapy…